Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
gptkb:cefazolin
|
| gptkbp:approvedBy |
gptkb:United_States
|
| gptkbp:ATCCode |
gptkb:J01DB04
|
| gptkbp:contraindication |
hypersensitivity to cephalosporins
|
| gptkbp:discoveredBy |
1967
|
| gptkbp:drugClass |
first-generation cephalosporin
|
| gptkbp:eliminationHalfLife |
1.8 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kefzol
|
| gptkbp:indication |
septicemia
endocarditis urinary tract infections respiratory tract infections skin and soft tissue infections bone and joint infections biliary tract infections perioperative prophylaxis |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
various
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
diarrhea
allergic reaction rash |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:cefazolin
|
| gptkbp:bfsLayer |
7
|